GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Gross Margin %

Qlife Holding AB (OSTO:QLIFE) Gross Margin % : 6,075.56% (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Qlife Holding AB's Gross Profit for the three months ended in Sep. 2023 was kr2.73 Mil. Qlife Holding AB's Revenue for the three months ended in Sep. 2023 was kr0.05 Mil. Therefore, Qlife Holding AB's Gross Margin % for the quarter that ended in Sep. 2023 was 6,075.56%.


The historical rank and industry rank for Qlife Holding AB's Gross Margin % or its related term are showing as below:

OSTO:QLIFE' s Gross Margin % Range Over the Past 10 Years
Min: -2667.71   Med: 47.86   Max: 171.97
Current: -2667.71


During the past 4 years, the highest Gross Margin % of Qlife Holding AB was 171.97%. The lowest was -2667.71%. And the median was 47.86%.

OSTO:QLIFE's Gross Margin % is ranked worse than
99.75% of 801 companies
in the Medical Devices & Instruments industry
Industry Median: 52.9 vs OSTO:QLIFE: -2667.71

Qlife Holding AB had a gross margin of 6,075.56% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Qlife Holding AB was 0.00% per year.


Qlife Holding AB Gross Margin % Historical Data

The historical data trend for Qlife Holding AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Gross Margin % Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Gross Margin %
- 171.97 47.86 -59.74

Qlife Holding AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 667.06 -4,395.89 5,080.49 9,236.96 6,075.56

Competitive Comparison of Qlife Holding AB's Gross Margin %

For the Medical Devices subindustry, Qlife Holding AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qlife Holding AB's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Gross Margin % falls into.



Qlife Holding AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Qlife Holding AB's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=-10.7 / 17.993
=(Revenue - Cost of Goods Sold) / Revenue
=(17.993 - 28.742) / 17.993
=-59.74 %

Qlife Holding AB's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=2.7 / 0.045
=(Revenue - Cost of Goods Sold) / Revenue
=(0.045 - -2.689) / 0.045
=6,075.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Qlife Holding AB  (OSTO:QLIFE) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Qlife Holding AB had a gross margin of 6,075.56% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Qlife Holding AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Qlife Holding AB (OSTO:QLIFE) Business Description

Traded in Other Exchanges
Address
Redaregatan 48, Helsingborg, SWE, SE-252 36
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines